[Mutagenesis tests. The problem of antibiotics and chemotherapeutic agents].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6764432)

Published in G Ital Chemioter on October 21, 1983

Authors

F Rodenghi, M Crippa, G Carniti, B P Goldstein

Articles by these authors

Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother (1983) 2.52

Sequence organization of the spacer in the ribosomal genes of Xenopus clivii and Xenopus borealis. Nucleic Acids Res (1981) 2.27

Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother (1995) 2.11

Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother (1998) 1.78

Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob Agents Chemother (1999) 1.69

Persistence in early amphibian embryos of informational RNA's from the lampbrush chromosome stage of oögenesis. Proc Natl Acad Sci U S A (1967) 1.55

Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung (1967) 1.54

Synthesis of amplified DNA that codes for ribosomal RNA. Proc Natl Acad Sci U S A (1971) 1.46

Xenopsin: the neurotensin-like octapeptide from Xenopus skin at the carboxyl terminus of its precursor. Proc Natl Acad Sci U S A (1984) 1.45

Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization. J Antibiot (Tokyo) (1991) 1.43

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. J Antibiot (Tokyo) (1981) 1.42

Genomic function during the lampbrush chromosome stage of amphibian oogenesis. Proc Natl Acad Sci U S A (1966) 1.28

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol. J Chemother (2005) 1.26

Transcription of spacer sequences in genes coding for ribosomal RNA in Xenopus cells. Proc Natl Acad Sci U S A (1979) 1.21

Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis. Antimicrob Agents Chemother (2005) 1.17

The primary ribosomal DNA transcript in eukaryotes. Prog Biophys Mol Biol (1977) 1.17

Interaction between rifampicin and trimethoprim in vitro and in experimental infections. J Antimicrob Chemother (1977) 1.16

Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother (1998) 1.15

In vitro bacteriological studies on rifamycin B diethylamide (rifamide). Arzneimittelforschung (1965) 1.15

Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations. Diagn Microbiol Infect Dis (1993) 1.14

Hybridization properties and sequence arrangement in a population of mRNAs. Nat New Biol (1973) 1.12

Large scale isolation of nuclei and nucleoli from vitellogenic oocytes of Xenopus laevis. Chromosoma (1978) 1.09

Spondylodiscitis caused by viridans streptococci: three cases and a review of the literature. Clin Rheumatol (1999) 1.06

Evidence for the appearance of novel gene products during amphibian blastulation. Proc Natl Acad Sci U S A (1968) 1.05

Inheritance of rDNA spacer length variants in man. Mol Gen Genet (1984) 1.02

Cor triatriatum. Clinical presentation and operative results. J Thorac Cardiovasc Surg (1991) 1.01

The rate of ribonucleic acid synthesis during the cell cycle. Exp Cell Res (1966) 1.00

Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin. Biochem J (1992) 0.99

In-vitro activity of nisin against clinical isolates of Clostridium difficile. J Chemother (2004) 0.97

Relative positions of the "repetitive", "unique" and poly(A) fragments of mRNA. Nature (1974) 0.96

Visualization of rDNA spacer transcription in Xenopus oocytes treated with fluorouridine. Exp Cell Res (1978) 0.96

Variations in the amount of polysomes in mature oocytes of Drosophila melanogaster. Dev Biol (1978) 0.94

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Trop Med Int Health (1999) 0.93

Antibiotic GE37468 A: a new inhibitor of bacterial protein synthesis. I. Isolation and characterization. J Antibiot (Tokyo) (1995) 0.93

Ribosomal RNA synthesis and RNA polymerase. Nature (1970) 0.92

New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci. J Antibiot (Tokyo) (1995) 0.90

Maternal and embryonic contributions to the functional messenger RNA of early development. Proc Natl Acad Sci U S A (1969) 0.89

Semisynthetic derivatives of purpuromycin as potential topical agents for vaginal infections. J Med Chem (1997) 0.89

The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of 1-methyl-2-nitro-5-vinylimidazole is DNA. J Gen Microbiol (1977) 0.89

The mechanism of action of nitro-heterocyclic antimicrobial drugs. Metabolic activation by micro-organisms. J Gen Microbiol (1977) 0.88

Changes in rate of RNA synthesis and ribosomal gene number during oogenesis of Drosophila melanogaster. Dev Biol (1977) 0.88

Sequence arrangement in mRNA: presence of poly(A) and identification of a repetitive fragment at the 5' end. Cold Spring Harb Symp Quant Biol (1974) 0.87

IVM--the first choice for IVF in Italy. Reprod Biomed Online (2006) 0.87

Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections. Antimicrob Agents Chemother (1992) 0.87

Structural analysis of a cDNA clone from Xenopus laevis containing a repetitive sequence element. Dev Biol (1982) 0.86

Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro. Antimicrob Agents Chemother (1979) 0.86

Mass fractionation of Drosophila egg chambers. Dev Biol (1977) 0.86

Differential susceptibilities of enterococcal species to elfamycin antibiotics. J Clin Microbiol (1994) 0.85

Compact structure of ribosomal chromatin in Xenopus laevis. Nucleic Acids Res (1984) 0.85

Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines. J Med Chem (1992) 0.85

Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study. Cancer (1991) 0.85

Structure and biological activity of lipiarmycin B. J Antibiot (Tokyo) (1988) 0.84

In vivo transcription of the spacer sequences of rDNA in Xenopus. Exp Cell Res (1977) 0.84

The synthesis of amplified ribosomal DNA. Cold Spring Harb Symp Quant Biol (1974) 0.83

Regulatory factor for the transcription of the ribosomal genes in amphibian oocytes. Nature (1970) 0.82

Purpuromycin: an antibiotic inhibiting tRNA aminoacylation. RNA (1997) 0.81

Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) (1996) 0.81

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP). Br J Cancer (1998) 0.81

A special form of deoxyribonucleic acid dependent ribonucleic acid polymerase from oocytes of Xenopus laevis. Isolation and characterization. Biochemistry (1974) 0.80

Transcriptional regulation of the murine urokinase-type plasminogen activator gene in skeletal myoblasts. Thromb Haemost (1999) 0.80

Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A). J Antibiot (Tokyo) (1997) 0.80

Synthesis and biological activity of some methyl-substituted diaminopimelic acids. Farmaco Sci (1974) 0.80

Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879. J Gen Microbiol (1993) 0.80

A40926 aglycone and pseudoaglycones: preparation and biological activity. J Antibiot (Tokyo) (1988) 0.80

An RNA-DNA complex intermediate in ribosomal gene amplification. Proc Natl Acad Sci U S A (1972) 0.79

Specific control of messenger translation in Drosophila oocytes and embryos. Dev Biol (1980) 0.79

DNA-dependent RNA polymerase C from Xenopus laevis ovaries: formation of stable heparin-resistant DNA-binding complexes. FEBS Lett (1976) 0.78

Synergic activity of teicoplanin and ethambutol against Mycobacterium tuberculosis. J Antimicrob Chemother (1994) 0.78

[Ambulatory monitoring of blood pressure profiles in in hypertensive patients 26-65 years of age]. Cardiologia (1995) 0.78

[Histological and histochemical techniques for serial sectioning and staining the cardiac nervous and conduction system]. Pathologica (1994) 0.78

Features and severity of occupational asthma upon diagnosis: an Italian multicentric case review. Allergy (2002) 0.77

In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial. J Clin Microbiol (2010) 0.77

Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity. J Antibiot (Tokyo) (1996) 0.77

Amides of de-acetylglucosaminyl-deoxy teicoplanin active against highly glycopeptide-resistant enterococci. Synthesis and antibacterial activity. J Antibiot (Tokyo) (1994) 0.77

Components of the GE2270 complex produced by Planobispora rosea ATCC 53773. J Antibiot (Tokyo) (1995) 0.77

Mechanism of action of purpuromycin. Biochem J (1992) 0.76

Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent. J Pharm Pharmacol (1982) 0.76

Disomic and diploid meiotic products in Saccharomyces cerevisiae. Effect of vincristine, vinblastine, adriamycin, bleomycin, mitomycin C and cyclophosphamide. Mutat Res (1983) 0.76

Structural analysis of repetitive sequence elements transcribed in early development of Xenopus laevis. Mol Biol Rep (1983) 0.76

[Blood rheology and fibrinogenemia: two independent parameters in the assessment of cerebral vascular damage]. Minerva Med (1995) 0.75

Mechanism of action of purpuromycin. Biochem J (1992) 0.75

A42867, a novel glycopeptide antibiotic. J Antibiot (Tokyo) (1989) 0.75

Different broth dilution procedures generate different apparent MICs for ramoplanin. J Antimicrob Chemother (1994) 0.75

Regarding "high prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm". J Vasc Surg (2001) 0.75

QuantiFERON-TB Gold test for healthcare workers. J Hosp Infect (2008) 0.75

Octapeptide derivatives of teicoplanin antibiotics. J Antibiot (Tokyo) (1993) 0.75

[Gastrokinetic effect of Vincamine]. Farmaco Prat (1975) 0.75

[Effects of Maitland's manual mobilization on the thoracic spine]. Rehabilitation (Stuttg) (2005) 0.75

Occupational exposure to pectinase. Allergy (2002) 0.75

[Design, development, and dosage control of individual compensatory filters for 6 MV X-ray radiotherapy]. Radiol Med (1995) 0.75

Translation "in vitro" of globin mRNA from Xenopus laevis. Cell Biol Int Rep (1978) 0.75

[Multiple occupational exposure to solvents]. G Ital Med Lav (1996) 0.75

Influence of individual factors and personal habits on the levels of biological indicators of exposure. Toxicol Lett (1995) 0.75

Antibiotic SB22484: a novel complex of the aurodox group. I. Taxonomy of the producing organism, isolation of the antibiotics and chemical and biological characterization. J Antibiot (Tokyo) (1990) 0.75

[Advantages of a system of positioning and localization made of thermo-conformable materials for irradiation of cervicofacial and encephalic lesions treated with stereotactic fractionated radiation]. Radiol Med (1995) 0.75

[Relationship between hemorheology and pro- and anti-coagulation factors in inflammatory and degenerative vascular diseases]. Minerva Med (1994) 0.75

[Stereotactic radiotherapy with linear accelerators. Dosage considerations on collimators and photon beam energy]. Radiol Med (1995) 0.75